Physician profile
Dale E Braun
NPI 1457352080
$4,314.22
in general payments reported to CMS, 2019-2025
23 companies · $588 in 2025
The $588 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $894 · 2020: $652 · 2021: $538 · 2022: $419 · 2023: $480 · 2024: $743 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,811.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $694.43 | 2021-2024 | Cornerstone Psr Cervical Fusion System, Unid_pass, Midas Rex |
| Nuvasive, INC. | $616.91 | 2019-2023 | Reline |
| Medtronic USA, INC. | $402.00 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $386.24 | 2019-2020 | |
| Centinel Spine, LLC | $317.59 | 2024-2025 | Prodisc L, Prodisc C Vivo |
| Orthofix Medical, INC. | $262.49 | 2020 | |
| Globus Medical, INC. | $205.76 | 2024-2025 | Elsa, Mars 3v/3vl, Excelsius Deformity |
| Depuy Synthes Sales INC. | $167.03 | 2023-2025 | Conduit |
| Cerapedics INC. | $161.63 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Arteriocyte Medical Systems, INC. | $139.51 | 2025 | Magellan |
| Nevro Corp. | $133.79 | 2021 | |
| Surgalign Spine Technologies, INC. | $133.49 | 2019 | |
| Zimvie INC. | $132.37 | 2022 | |
| Si-Bone, INC. | $130.46 | 2021 | |
| Stryker Corporation | $125.00 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $124.92 | 2025 | Stimulan |
| Vertex Pharmaceuticals Incorporated | $48.66 | 2024-2025 | |
| Davol INC. | $38.27 | 2025 | Arista |
| Octapharma USA, INC. | $25.84 | 2024 | Balfaxar |
| Ethicon US, LLC | $21.66 | 2021 | |
| Integra Lifesciences Corporation | $18.97 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Olympus America INC. | $14.24 | 2023 | |
| Assertio Therapeutics, INC. | $12.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Braun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.